使:

Brian P Lee1, Katie Witkiewitz2, Jessica Mellinger3

  • 1Division of Gastroenterology and Liver Diseases, University of Southern California Keck School of Medicine and Institute for Addiction Science, University of Southern California, Los Angeles, CA, USA.

概括

在患有酒精相关性肝病 (ALD) 的患者中,治疗酒精使用障碍至关重要. 专家建议侧重于临床试验设计,以评估减少酒精摄入量是否改善肝脏结果.